DBV Technologies | Capital Ordinário



Ordinary Share Capital Alterar Data
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amarin USD 308.15M 2.85M 2025-03
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
DBV Technologies USD 11.65M 1000 2025-03
Halozyme Therapeutics USD 117.62M 117.5M 2025-06
Incyte USD 194.12M 193.93M 2025-06
Insmed USD 211.11M 209.29M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
PTC Therapeutics USD 79.38M 79.3M 2025-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
United Therapeutics USD 45.22M 44.42M 2025-06


DBV Technologies Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.